ITAMIONE
140MG EMP MED 10
| SÚKL code | 0264733 |
|---|---|
| Name of the product | ITAMIONE |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ITAMIONE |
| Supplement | 140MG EMP MED 10 |
| Strenght | 140MG |
| Pharmaceutical form | Medicated plaster |
| Package | 10 |
| Route | Cutaneous use |
| Language of the pack | Czech |
| Wrap type | Sachet |
| Legal status | OTC medicinal products |
| Active substance | DICLOFENAC SODIUM (DICLOFENACUM NATRICUM) |
| ATC group | M02AA15 |
| ATC group name | DIKLOFENAK |
Marketing authorisation information
| Registration Number | 29/ 121/19-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 10. 2022 |
| MA Holder | GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz